Le Lézard
Classified in: Health
Subject: AWD

Richard T. Yung, M.D., F.A.C.S., is recognized by Continental Who's Who


SCARSDALE, N.Y., Oct. 19, 2017 /PRNewswire/ -- Richard T. Yung, M.D., F.A.C.S., is recognized by Continental Who's Who as a Pinnacle Professional in the field of Healthcare. Dr. Yung is an Otolaryngologist and Facial Plastic Surgeon with ENT & Allergy Associates.

Established in 1998, ENT & Allergy Associates has grown to be home to nearly 170 physicians practicing in over forty locations across the New York tri-state area.

An esteemed otolaryngologist garnering twenty three years of experience, Dr. Yung specializes in adult and pediatric ear, nose and throat health, snoring and sleep disorders, as well as performing various facial and reconstructive plastic surgeries.

Board Certified by the American Board of Otolaryngology, Dr. Yung is a member of the American Medical Association, American Academy of Otolaryngology-Head and Neck Surgery and the American Academy of Facial Plastic and Reconstructive Surgery.

Dr. Yung has received numerous honors and awards throughout the course of his career. The recipient of the 1995 Norman E. Stoller Award for the best surgical resident at Beth Israel Medical Center, he earned the 1999 New York Medical College Resident Teaching Award. The following year, Dr. Yung received the John Orlando Roe Award for Best Clinical Research in Facial Plastic Surgery by a Fellow. Most recently, Dr. Yung was honored with the 2016 Top Doctor Award.

Dr. Yung earned his Medical degree from the Columbia University College of Physicians and Surgeons following his undergraduate degree in Chemistry from Johns Hopkins University. He served his otolaryngology residency at The New York Eye & Ear Infirmary, followed by a Facial Plastic and Reconstructive Surgery Fellowship at Buckhead Facial Plastic Surgery in Atlanta, GA.

For more information, please visit www.entandallergy.com.  

Contact: Katherine Green, 516-825-5634, [email protected]  

SOURCE Continental Who's Who


These press releases may also interest you

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...

at 18:01
Aflac Incorporated announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid...



News published on and distributed by: